Your browser doesn't support javascript.
loading
Response to Letter to the Editor "Intravenous brivaracetam and lorazepam for acute seizure control: Are they equally effective?"
Szaflarski, Jerzy P; Sadek, Ahmed; Greve, Bernhard; Williams, Paulette; Varner, Julie A; Moseley, Brian D.
Affiliation
  • Szaflarski JP; University of Alabama at Birmingham, Department of Neurology, The UAB Epilepsy Center, 1719 6th Avenue South, CIRC 312, Birmingham, AL 35294, USA. Electronic address: jszaflarski@uabmc.edu.
  • Sadek A; Neurological Services of Orlando, 3849 Oakwater Circle, Orlando, FL 32806, USA. Electronic address: ahsadek@mac.com.
  • Greve B; UCB Pharma, Alfred-Nobel-Straße 10, 40789 Monheim am Rhein, Germany. Electronic address: bernhard.greve@ucb.com.
  • Williams P; UCB Pharma, 8010 Arco Corporate Drive, Raleigh, NC 27617, USA. Electronic address: paulette.williams@ucb.com.
  • Varner JA; UCB Pharma, 8010 Arco Corporate Drive, Raleigh, NC 27617, USA. Electronic address: julie.varner@ucb.com.
  • Moseley BD; University of Cincinnati, 260 Stetson Street, Suite 2300, Cincinnati, OH 45267-0525, USA. Electronic address: briandmoseley@gmail.com.
Epilepsy Behav ; 113: 107512, 2020 12.
Article in En | MEDLINE | ID: mdl-33158738

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrrolidinones / Lorazepam Limits: Humans Language: En Journal: Epilepsy Behav Journal subject: CIENCIAS DO COMPORTAMENTO / NEUROLOGIA Year: 2020 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrrolidinones / Lorazepam Limits: Humans Language: En Journal: Epilepsy Behav Journal subject: CIENCIAS DO COMPORTAMENTO / NEUROLOGIA Year: 2020 Document type: Article
...